Medpace Holdings [MEDP] vs Waters [WAT] Detailed Stock Comparison

Medpace Holdings Inc.

NASDAQ
Loading...

Waters Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Medpace Holdings Inc. wins in 12 metrics, Waters Corporation wins in 8 metrics, with 0 ties. Medpace Holdings Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medpace Holdings Inc. Waters Corporation Better
P/E Ratio (TTM) 26.90 28.90 Medpace Holdings Inc.
Price-to-Book Ratio 25.37 7.24 Waters Corporation
Debt-to-Equity Ratio 20.43 60.28 Medpace Holdings Inc.
PEG Ratio 1.75 -9.39 Medpace Holdings Inc.
EV/EBITDA 18.94 28.78 Medpace Holdings Inc.
Profit Margin (TTM) 17.19% 20.30% Waters Corporation
Operating Margin (TTM) 20.03% 33.76% Waters Corporation
EBITDA Margin (TTM) 20.03% 33.76% Waters Corporation
Return on Equity 77.25% 29.28% Medpace Holdings Inc.
Return on Assets (TTM) 17.47% 11.52% Medpace Holdings Inc.
Free Cash Flow (TTM) $681.87M $539.81M Medpace Holdings Inc.
1-Year Return 56.69% 3.87% Medpace Holdings Inc.
Price-to-Sales Ratio (TTM) 4.38 9.65 Medpace Holdings Inc.
Enterprise Value $11.19B $31.49B Waters Corporation
EV/Revenue Ratio 4.18 9.95 Medpace Holdings Inc.
Gross Profit Margin (TTM) 27.78% 61.08% Waters Corporation
Revenue per Share (TTM) $94 $53 Medpace Holdings Inc.
Earnings per Share (Diluted) $15.26 $10.77 Medpace Holdings Inc.
Beta (Stock Volatility) 1.39 1.20 Waters Corporation
Short % of Float 5.30% 3.38% Waters Corporation

Medpace Holdings Inc. vs Waters Corporation Stock Performance Analysis

Loading Price Chart...

MEDP
WAT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings Inc.0.03%2.10%12.58%3.06%-16.39%-18.13%
Waters Corporation0.63%-1.54%8.67%23.36%-7.18%-6.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings Inc.56.69%110.68%163.23%1,566.69%1,566.69%1,566.69%
Waters Corporation3.87%32.07%3.74%165.28%286.07%736.74%

Performance & Financial Health Analysis: Medpace Holdings Inc. vs Waters Corporation

MetricMEDPWAT
Market Information
Market Cap i$11.72B$30.55B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i574,912809,747
90 Day Avg. Volume i396,354944,136
Last Close$467.50$357.76
52 Week Range$294.07 - $628.92$275.05 - $414.15
% from 52W High-25.67%-13.62%
All-Time High$628.92 (Jan 16, 2026)$428.22 (Sep 06, 2021)
% from All-Time High-25.67%-16.45%
Growth Metrics
Quarterly Revenue Growth0.27%0.07%
Quarterly Earnings Growth0.08%-0.03%
Financial Health
Profit Margin (TTM) i0.17%0.20%
Operating Margin (TTM) i0.20%0.34%
Return on Equity (TTM) i0.77%0.29%
Debt to Equity (MRQ) i20.4360.28
Cash & Liquidity
Book Value per Share (MRQ)$16.18$43.01
Cash per Share (MRQ)$22.85$5.99
Operating Cash Flow (TTM) i$739.17M$652.56M
Levered Free Cash Flow (TTM) i$514.58M$427.16M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Medpace Holdings Inc. vs Waters Corporation

MetricMEDP (Apr 26, 2026)WAT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i26.9028.90
Forward P/E i21.9719.04
PEG Ratio i1.75-9.39
Price to Sales (TTM) i4.389.65
Price to Book (MRQ) i25.377.24
Market Capitalization
Market Capitalization i$11.72B$30.55B
Enterprise Value i$11.19B$31.49B
Enterprise Value Metrics
Enterprise to Revenue i4.189.95
Enterprise to EBITDA i18.9428.78
Risk & Other Metrics
Beta i1.391.20
Book Value per Share (MRQ) i$16.18$43.01

Financial Statements Comparison: Medpace Holdings Inc. vs Waters Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMEDP (2025)WAT (2025)
Revenue/Sales i2.53B3.17B
Cost of Goods Sold i1.77B1.29B
COGS % of Revenue i69.9%40.7%
Gross Profit i760.62M1.88B
Gross Margin i30.1%59.3%
Research & Development iN/A195.71M
Operating Income (EBIT) i534.94M802.59M
Operating Margin i21.1%25.4%
EBITDA i570.79M1.03B
EBITDA Margin i22.6%32.6%
Pre-Tax Income i542.38M754.88M
Pre-Tax Income % of Revenue i21.4%23.8%
Income Tax i91.25M112.25M
Income Tax % of Revenue i3.6%3.5%
Net Income (Profit) i451.12M642.63M
Profit Margin i17.8%20.3%

Balance Sheet & Liquidity Metrics

MetricMEDP (2025)WAT (2025)
Cash & Equivalents i497.05M587.83M
Total Current Assets i989.62M2.15B
Total Current Assets % of Revenue i39.1%67.8%
Total Current Liabilities i1.34B1.24B
Total Current Liabilities % of Revenue i53.1%39.2%
Long-Term Debt i113.64M999.99M
Long-Term Debt % of Revenue i4.5%31.6%
Total Shareholders Equity i459.07M2.56B
Retained Earnings i-459.98M10.43B
Retained Earnings % of Revenue i-18.2%329.6%
Property, Plant & Equipment i171.17M824.49M

Cash Flow Statement Comparison

MetricMEDP (2025)WAT (2025)
Operating Cash Flow i643.24M652.56M
Operating Cash Flow % of Revenue i25.4%20.6%
Capital Expenditures i-31.36M-112.75M
Free Cash Flow i681.87M539.81M
FCF Margin i26.9%17.1%
Debt Repayment i0-290.00M
Common Stock Repurchase i-917.39M-14.67M

Short Interest & Institutional Ownership Analysis

MetricMEDPWAT
Shares Short i1.22M3.32M
Short Ratio i3.932.98
Short % of Float i5.30%3.38%
Shares Outstanding i28.56M59.55M
Float Shares i23.01M97.96M
% Held by Insiders i19.39%0.11%
% Held by Institutions i86.88%63.35%
% Held by Public i-6.27%36.54%

Dividend Analysis & Yield Comparison: Medpace Holdings Inc. vs Waters Corporation

MetricMEDPWAT
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A